I. Paul Singh, MD; and William F. Wiley, MD
Show Description +
Is the variety of IOL options for treating presbyopia ever too much of a good thing? As William F. Wiley, MD, explains in this episode of Innovation Journal Club, the easy answer is 'no.' The harder job for clinicians, he says, are figuring out where they all fit in clinical practice.
Posted: 8/31/2022
I. Paul Singh, MD; and William F. Wiley, MD
Is the variety of IOL options for treating presbyopia ever too much of a good thing? As William F. Wiley, MD, explains in this episode of Innovation Journal Club, the easy answer is 'no.' The harder job for clinicians, he says, are figuring out where they all fit in clinical practice.
Posted: 8/31/2022
Supported by
Please log in to leave a comment.